Literature DB >> 2727474

A comparison of estimated proportional hazards models and regression trees.

M R Segal1, D A Bloch.   

Abstract

We present examples of the usage of regression trees for censored response via two real world datasets, one a rheumatoid arthritis survival study and the other a hip replacement study, and draw comparisons with the results of Cox proportional hazards modelling. The two methods pursue different goals. Motivation of the tree techniques is the desire to extract meaningful prognostic groups while the proportional hazards model enables assessment of the impact of risk factors. The methods are thus complementary. For the arthritis study the two techniques corroborate one another, although the flavour of the conclusions derived differ. For the hip replacement study, however, the regression tree approach reveals structure that would not emerge from a routine proportional hazards analysis. We also discuss the treatment of data analytic issues such as the handling of missing values and influence in the presence of non-uniform censoring.

Entities:  

Mesh:

Year:  1989        PMID: 2727474     DOI: 10.1002/sim.4780080503

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.

Authors:  Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Fuminaka Sugauchi; Akihiro Tamori; Sei Kakinnuma; Kentaro Matsuura; Namiki Izumi
Journal:  J Gastroenterol       Date:  2011-06-17       Impact factor: 7.527

2.  Polymorphisms in microRNA-related genes are associated with survival of patients with T-cell lymphoma.

Authors:  Xi Li; Xiaobo Tian; Bo Zhang; Jieping Chen
Journal:  Oncologist       Date:  2014-02-21

Review 3.  Prognostic factors: rationale and methods of analysis and integration.

Authors:  G M Clark; S G Hilsenbeck; P M Ravdin; M De Laurentiis; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Classification and regression trees (CART) for estimation of prognosis in patients with gastric carcinoma.

Authors:  P Hermanek; I Guggenmoos-Holzmann
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program.

Authors:  E Susan Amirian; J Clay Goodman; Pamela New; Michael E Scheurer
Journal:  J Neurooncol       Date:  2014-01-05       Impact factor: 4.130

6.  Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

Authors:  Denah R Taggart; Wendy B London; Mary Lou Schmidt; Steven G DuBois; Tom F Monclair; Akira Nakagawara; Bruno De Bernardi; Peter F Ambros; Andrew D J Pearson; Susan L Cohn; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 7.  Construction and analysis of multiparameter prognostic models for melanoma outcome.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  Methods Mol Biol       Date:  2014

8.  Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.

Authors:  Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Hiroshi Yatsuhashi; Namiki Izumi
Journal:  J Gastroenterol       Date:  2010-09-10       Impact factor: 7.527

9.  A nomogram for individualized estimation of survival among patients with brain metastasis.

Authors:  Jill S Barnholtz-Sloan; Changhong Yu; Andrew E Sloan; Jaime Vengoechea; Meihua Wang; James J Dignam; Michael A Vogelbaum; Paul W Sperduto; Minesh P Mehta; Mitchell Machtay; Michael W Kattan
Journal:  Neuro Oncol       Date:  2012-04-27       Impact factor: 12.300

10.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.

Authors:  F Jänicke; M Schmitt; L Pache; K Ulm; N Harbeck; H Höfler; H Graeff
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.